Free Trial
Jasper Hellweg

Jasper Hellweg Analyst Performance

Security Analyst at Argus

Jasper Hellweg is a stock analyst at Argus focused in the medical sector, covering 17 publicly traded companies. Over the past year, Jasper Hellweg has issued 3 stock ratings, including buy and hold recommendations. While full access to Jasper Hellweg's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jasper Hellweg's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
27 Last 8 Years
Buy Recommendations
85.19% 23 Buy Ratings
Companies Covered
17 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy85.2%23 ratings
Hold14.8%4 ratings
Sell0.0%0 ratings

Out of 27 total stock ratings issued by Jasper Hellweg at Argus, the majority (85.2%) have been Buy recommendations, followed by 14.8% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
52.9% of companies on NYSE
9 companies
NASDAQ
47.1% of companies on NASDAQ
8 companies

Jasper Hellweg, an analyst at Argus, currently covers 17 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
15 companies
88.2%
Computer and Technology
1 company
5.9%
Business Services
1 company
5.9%

Jasper Hellweg of Argus specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Business Services companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
8 companies
47.1%
MED PRODUCTS
2 companies
11.8%
MED - DRUGS
1 company
5.9%
MEDICAL SERVICES
1 company
5.9%
INTERNET SOFTWARE
1 company
5.9%
MED - OUTP/HM CRE
1 company
5.9%
FINANCIAL TRANSACTION SERVICES
1 company
5.9%
MED INSTRUMENTS
1 company
5.9%
MED - HOSPITALS
1 company
5.9%

About Jasper Hellweg

Jasper covers the Pharmaceutical and Biotech industries in the Healthcare segment. Prior to joining Argus, he worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing. Jasper began his career at Argus in the research department and has since widened his scope to include contributing to the Market Movers and Market Digest publications, the Vickers Weekly Insider Report, and Argus’ bespoke research on IPOs. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing.
Follow on LinkedIn

Jasper Hellweg's Ratings History at Argus

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Amgen Inc. stock logo
AMGN
Amgen
2/6/2026Boost Price Target$376.19$400.00Buy
Baxter International Inc. stock logo
BAX
Baxter International
10/31/2025Downgrade$19.17Hold
Zoetis Inc. stock logo
ZTS
Zoetis
9/9/2025Reiterated Rating$151.26$190.00Buy
Biogen Inc. stock logo
BIIB
Biogen
4/4/2025Downgrade$130.71Hold